Correspondence on 'A pilot study of tofacitinib for refractory Behçet's syndrome'.

Zou, Jun; Lin, Chen-Hong; Wang, Yan; Shen, Yan; Guan, Jian-Long

Zou, Jun; Lin, Chen-Hong; Wang, Yan; Shen, Yan; Guan, Jian-Long.

Afiliación

Zou J; Division of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Lin CH; Division of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Wang Y; Department of Ophthalmology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Shen Y; Division of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai, China.
Guan JL; Division of Rheumatology and Immunology, Huadong Hospital Affiliated to Fudan University, Shanghai, China jianlong_guan@126.com.

Ann Rheum Dis ; 82(4): e100, 2023 04.

Article en En | MEDLINE | ID: mdl-33495153

Asunto(s)

Síndrome de Behçet; Humanos; Síndrome de Behçet/complicaciones; Síndrome de Behçet/tratamiento farmacológico; Proyectos Piloto; Piperidinas/uso terapéutico; Pirimidinas/uso terapéutico

Palabras clave

Behcet syndrome; biological therapy; patient reported outcome measures

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Síndrome de Behçet Aspecto: Patient_preference Límite: Humans Idioma: En Revista: Ann Rheum Dis Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google